TREA

87284523 - COMPUGEN

Follow

Information

  • Trademark
  • 87284523
  • Serial Number
    87284523
  • Registration Number
    5640243
  • Filing Date
    December 29, 2016
    7 years ago
  • Registration Date
    January 01, 2019
    5 years ago
  • Transaction Date
    February 28, 2024
    3 months ago
  • Status Date
    January 01, 2019
    5 years ago
  • Published for Opposition Date
    October 16, 2018
    5 years ago
  • Location Date
    January 01, 2019
    5 years ago
  • First Use Anywhere Date
    September 08, 2004
    19 years ago
  • First Use In Commerce Date
    September 08, 2004
    19 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    REEVES, APRIL ELIZABET
  • Attorney Docket Number
    0-16-328(TM1
    Attorney Name
    Kevin D. McCarthy
    Law Office Assigned Location Code
    N60
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
COMPUGEN
Case File Statements
  • GS0051: (Based on 44(e)) biological preparations featuring antibodies for the treatment of cancer, inflammatory diseases, autoimmune diseases, neurological diseases, cardiovascular diseases, metabolic diseases, gastrointestinal diseases; anti-cancer preparations; biological preparations for the treatment of cancer inflammatory diseases, autoimmune diseases, neurological diseases, cardiovascular diseases, metabolic diseases, gastrointestinal diseases; biopharmaceuticals for the treatment of cancer; diagnostic reagents for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases
  • GS0451: (Based on 44(e)) Licensing of intellectual property rights
  • GS0421: (Based on Use in Commerce) (Based on 44(e)) Drug discovery services; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of genetics; research and development in the field of diagnostic preparations; research in the field of pharmacogenetics; conducting clinical trials for pharmaceuticals; pharmaceutical research and development; research and development in the field of pharmaceuticals for the pharmaceutical industry; conducting early evaluations in the field of new pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; structural and functional analysis of genomes; DNA screening for scientific research purposes; biochemical research and analysis; laboratory research in the field of pharmaceuticals; research and development services in the field of immunology; medical research in the nature of computerized genetic analysis of DNA
Case File Event Statements
  • 2/27/2024 - 3 months ago
    27 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 1/1/2024 - 5 months ago
    26 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 1/1/2019 - 5 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/16/2018 - 5 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 10/16/2018 - 5 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 9/26/2018 - 5 years ago
    22 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 9/6/2018 - 5 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 8/17/2018 - 5 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 8/17/2018 - 5 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 8/15/2018 - 5 years ago
    18 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 5/6/2018 - 6 years ago
    17 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 5/6/2018 - 6 years ago
    16 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 5/6/2018 - 6 years ago
    15 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 4/26/2018 - 6 years ago
    14 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Type: RCCK
  • 10/14/2017 - 6 years ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 10/14/2017 - 6 years ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 10/14/2017 - 6 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 9/19/2017 - 6 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/19/2017 - 6 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/15/2017 - 6 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 9/7/2017 - 6 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/2/2017 - 7 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/2/2017 - 7 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/2/2017 - 7 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/26/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/10/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/2/2017 - 7 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP